Arthur Tzianabos, Interim Executive Chair: Stoke Therapeutics STOK Sell · Filed 03/12

Trade details

Type: Insider sale
Amount: $174,200
Shares · price: 4,355 sh · $40.00 a share
Held after: 31,339 sh
Stock: Stoke Therapeutics STOK
Person: Arthur TzianabosInterim Executive Chair
Trade date: 26/03/10
Filed: 26/03/12
Days to filing: 2 days

Sold 12.2% of holdings

Share of holding sold: 12.2%

Stoke Therapeutics trades, last 26 weeks

What else happened in Stoke Therapeutics around then

Filed or reported within 30 days of the trade day · 02/08~04/09

Arthur Tzianabos's recent trades

Arthur TzianabosDirector
Planned sale10b5-1 planStoke Therapeutics
Planned sale10b5-1 plan
Stoke Therapeutics
STOK
$3.5M
90,508 sh
$3.5M
Filed 03/10
Traded 03/10
Arthur TzianabosDirector
SellQ32 Bio
Sell
Q32 Bio
QTTB
$6,413
265 sh
$6,413
Filed 24/08/14
Traded 24/03/25
Arthur TzianabosDirector
Sell10b5-1 planQ32 Bio
Sell10b5-1 plan
Q32 Bio
QTTB
$7,431
13,037 sh
$7,431
Filed 24/02/15
Traded 24/01/09
Arthur TzianabosDirector
SellQ32 Bio
Sell
Q32 Bio
QTTB
$14.8K
10,616 sh
$14.8K
Filed 23/01/11
Traded 23/01/09

Arthur Tzianabos, Chairman — sold $174.2K of Stoke Therapeutics STOK · 12.2% of holdings · 10b5-1 plan | Whalegun